ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 159 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q2 2018. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $1,966,000 | +512.5% | 14,202 | +88.8% | 0.21% | +583.9% |
| Q4 2019 | $321,000 | -25.7% | 7,521 | +20.7% | 0.03% | +29.2% |
| Q1 2019 | $432,000 | -71.2% | 6,229 | -68.2% | 0.02% | -73.9% |
| Q3 2018 | $1,498,000 | +427.5% | 19,617 | +430.9% | 0.09% | +607.7% |
| Q2 2018 | $284,000 | -17.0% | 3,695 | -49.9% | 0.01% | -27.8% |
| Q4 2017 | $342,000 | – | 7,372 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iguana Healthcare Management, LLC | 75,000 | $5,084,000 | 2.52% |
| COLUMBIA WANGER ASSET MANAGEMENT LLC | 1,237,825 | $83,900,000 | 1.18% |
| CAPITAL INTERNATIONAL LTD /CA/ | 206,718 | $14,011,000 | 0.91% |
| Cormorant Asset Management, LP | 75,000 | $5,084,000 | 0.74% |
| Capital International Sarl | 107,450 | $7,283,000 | 0.63% |
| Rock Springs Capital Management LP | 159,750 | $10,828,000 | 0.62% |
| Opus Point Partners Management, LLC | 12,201 | $827,000 | 0.61% |
| Hood River Capital Management LLC | 109,629 | $7,431,000 | 0.56% |
| Aureus Asset Management, LLC | 50,740 | $2,927,000 | 0.51% |
| ROCKEFELLER FINANCIAL SERVICES INC | 374,663 | $25,395,000 | 0.51% |